Safety and Efficacy of Nabilone in Alzheimer's Disease

Clinical trial NCT02351882 · COMPLETED

Trial details

NCT number: NCT02351882
Sponsor: Sunnybrook Health Sciences Centre
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease Agitation Weight Loss Pain Oxidative Stress

Start date: 2015-01-01
Primary completion: 2018-01-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.